Linezolid structure
|
Common Name | Linezolid | ||
|---|---|---|---|---|
| CAS Number | 165800-03-3 | Molecular Weight | 337.346 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 585.5±50.0 °C at 760 mmHg | |
| Molecular Formula | C16H20FN3O4 | Melting Point | 176-1780C | |
| MSDS | Chinese USA | Flash Point | 307.9±30.1 °C | |
| Symbol |
GHS08 |
Signal Word | Danger | |
Use of LinezolidLinezolid (PNU-100766) is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. |
| Name | linezolid |
|---|---|
| Synonym | More Synonyms |
| Description | Linezolid (PNU-100766) is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. |
|---|---|
| Related Catalog | |
| References |
[1]. Clemett D, Markham A. Linezolid. Drugs. 2000 Apr;59(4):815-27; discussion 828. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 585.5±50.0 °C at 760 mmHg |
| Melting Point | 176-1780C |
| Molecular Formula | C16H20FN3O4 |
| Molecular Weight | 337.346 |
| Flash Point | 307.9±30.1 °C |
| Exact Mass | 337.143799 |
| PSA | 71.11000 |
| LogP | 0.30 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.554 |
| Storage condition | Store at RT |
| Precursor 10 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Complete genome sequencing and comparative analysis of the linezolid-resistant Enterococcus faecalis strain DENG1.
Arch. Microbiol. 196(7) , 513-6, (2014) Genome level analysis of bacterial strains provides information on genetic composition and resistance mechanisms to clinically relevant antibiotics. To date, whole genome characterization of linezolid... |
|
|
Gingival pain: an unusual side effect of ziprasidone.
BMJ Case Rep. 2013 , doi:10.1136/bcr-2012-007577, (2013) The patient is a 52-year-old man with schizophrenia who developed severe, unremitting gingival pain after his ziprasidone dosage was increased from 80 to 120 mg. His physical examination and laborator... |
|
|
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
N. Engl. J. Med. 370(23) , 2169-79, (2014) Dalbavancin, a lipoglycopeptide antibiotic agent that is active against gram-positive pathogens, has a long plasma half-life, allowing for once-weekly dosing. DISCOVER 1 and DISCOVER 2 were identicall... |
| Linezolid |
| NDA 21-130 Zyvox |
| N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide |
| Linezlid |
| Zyvoxid |
| Acetamide, N-(((5S)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)- |
| Zyvox |
| (S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide |
| N-{[(5S)-3-(3-Fluor-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamid |
| N-({(5S)-3-[3-Fluor-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamid |
| Zyvoxam |
| Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- |
| N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide |
| Zyvoxa |
| MFCD00937825 |
| N-({(5S)-3-[3-Fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide |
| N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide |
| N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphényl)-2-oxo-1,3-oxazolidin-5-yl]méthyl}acétamide |
| N-({(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide |